EUVIMED · CrossrefJournal
EuroIntervention
ISSN 1774-024X · Europa Digital & Publishing
Latest articles
Acute right ventricular response to transcatheter tricuspid valve replacement
Case volume and hospital mortality in patients undergoing transcatheter aortic valve implantation
Bioprosthetic valve performance of transcatheter aortic valves
Simultaneous leaflet laceration and valve fracture or remodelling in valve-in-valve transcatheter aortic valve interventions: the “crack-LLAMACORN” technique
Transcatheter tricuspid valve replacement after failed edge-to-edge repair
Early outcomes of tricuspid valve replacement in patients with tricuspid regurgitation: the Trisol Early Feasibility Study
Simultaneous biventricular pressure-volume loop analysis during transcatheter tricuspid valve replacement
Beyond drug-trial logic: designing interpretable procedural trials in interventional cardiology
Three-year outcomes of balloon-expandable valve-in-valve aortic valve implantation for failed transcatheter versus surgical valves
Bicuspid aortic valve phenotypes and transcatheter aortic valve implantation feasibility in an all-comers population with severe aortic stenosis
Anterior mitral leaflet modification to prevent left ventricular outflow tract obstruction during transcatheter mitral valve replacement: the PROTECT-LVOT registry
Losing “function” but gaining flow: reframing right ventricular assessment in transcatheter tricuspid valve replacement
Valve-in-valve transcatheter aortic valve implantation at three years: reassuring, provided you get there
Low-dose, short-duration catheter-directed thrombolysis for acute intermediate-high-risk pulmonary embolism: the BETULA trial
Comparison of self-expanding transcatheter heart valves for aortic stenosis: the multicentre, randomised, controlled, non-inferiority DOUBLE-CHOICE trial
Long-term clinical benefit after radiofrequency renal denervation: pooled 36-month results from the SPYRAL Clinical Program
Prasugrel should be preferred over ticagrelor in acute coronary syndromes: pros and cons
Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisation
Hertz contact intravascular lithotripsy for calcified coronary artery disease: the PINNACLE-I trial
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: final 7-year results of the COMPARE-ABSORB trial
Optimal timing of aspirin discontinuation with ticagrelor monotherapy in acute coronary syndrome: a post hoc comparative analysis from the TICO and T-PASS trials
Incidence, predictors, and clinical impact of hypoattenuating leaflet thickening following SAPIEN 3 Ultra RESILIA implantation
Management of patients with transvalvular right ventricular leads undergoing transcatheter tricuspid valve interventions: a scientific statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC endorsed by the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society and the Canadian Heart Rhythm Society
Prevalence, classification, and treatment of residual shunt after patent foramen ovale closure
SESAME technique: septal scoring along the midline endocardium
Transcatheter aortic valve implantation in pure aortic regurgitation: one-year outcomes of the AURORA trial
Coronary flow and resistance patterns indexed by subtended myocardial mass in coronary microvascular dysfunction
Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I study
Treatment of patent foramen ovale
Pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing percutaneous coronary intervention: the POMPEII Registry
EUVIMED